Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of British Columbia

$55,417.00

Evaluating antipsychotic drug-induced glucose dysregulation in a preclinical model: a crucial role for peripheral catecholamines

EF 2010-11

Résumé
Background: Antipsychotic medication is associated with a constellation of metabolic abnormalities, including weight gain, an imbalance between glucose and insulin actions, and higher than normal lipid content. Therefore, psychiatric patients are at increased risk for Type II Diabetes and cardiovascular disease when undergoing therapeutic treatment. Our aim is to determine the mechanisms underlying antipsychotic drug-induced glucose dysregulation. By utilizing animal models and state-of-the-art techniques, our research will return translational knowledge that will be applicable to a clinical standpoint. Methods: The "gold-standard" technique to assess insulin resistance, insulin secretion, and whole-body glucose turnover (hyperinsulinemic-euglycemic & hyperglycemic clamps) will be used in conjunction with labeled-glucose tracers, surgical preparations, and pharmacological methods to quantify, assess and verify epinephrine (E) and norepinephrine (NE) roles in drug-induced elevated glucose and the improper functioning of insulin. This novel proposed mechanism will high-light different antipsychotic drugs and their propensity to induce glucose abnormalities in the periphery. Results: Current analysis indicates that antipsychotic drugs have a differing effect on glucose metabolism, and over time there appears to be a modest tolerance effect that stays intact. We have several lines of evidence that elicit E and NE as key players in antipsychotic drug-induced glucose dysregulation and have recently developed a protocol to accurately detect minute amounts of these vital compounds with respect to time in rodent plasma. Conclusion: By utilizing these sophisticated protocols in whole conscious animal preparations, we will gain a better understanding to the direct metabolic side effects attributed to antipsychotic medications. Crucial target tissues (liver, pancreas and adrenal glands) and their peripheral receptors will mechanistically function as detailed starting points.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
229556
Name
Boyda Heidi N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Evaluating antipsychotic drug-induced glucose dysregulation in a preclinical model: a crucial role for peripheral catecholamines
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$55,417
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antipsychotic Drugs; Glucose Intolerance; Insulin Resistance; Mechanisms Of Action; Metabolic Side-Effects; Translational Animal Model; Type Ii Diabetes; Weight Gain
Abstract
Background: Antipsychotic medication is associated with a constellation of metabolic abnormalities, including weight gain, an imbalance between glucose and insulin actions, and higher than normal lipid content. Therefore, psychiatric patients are at increased risk for Type II Diabetes and cardiovascular disease when undergoing therapeutic treatment. Our aim is to determine the mechanisms underlying antipsychotic drug-induced glucose dysregulation. By utilizing animal models and state-of-the-art techniques, our research will return translational knowledge that will be applicable to a clinical standpoint. Methods: The "gold-standard" technique to assess insulin resistance, insulin secretion, and whole-body glucose turnover (hyperinsulinemic-euglycemic & hyperglycemic clamps) will be used in conjunction with labeled-glucose tracers, surgical preparations, and pharmacological methods to quantify, assess and verify epinephrine (E) and norepinephrine (NE) roles in drug-induced elevated glucose and the improper functioning of insulin. This novel proposed mechanism will high-light different antipsychotic drugs and their propensity to induce glucose abnormalities in the periphery. Results: Current analysis indicates that antipsychotic drugs have a differing effect on glucose metabolism, and over time there appears to be a modest tolerance effect that stays intact. We have several lines of evidence that elicit E and NE as key players in antipsychotic drug-induced glucose dysregulation and have recently developed a protocol to accurately detect minute amounts of these vital compounds with respect to time in rodent plasma. Conclusion: By utilizing these sophisticated protocols in whole conscious animal preparations, we will gain a better understanding to the direct metabolic side effects attributed to antipsychotic medications. Crucial target tissues (liver, pancreas and adrenal glands) and their peripheral receptors will mechanistically function as detailed starting points.
Competitiondate
201010
Approvedterm2
1 yr 7 mths
Pinamesdelim
Boyda, Heidi N
Approvedterm
1 an 7 mois
Cihrcontribution2
~ $55,417~ $0~